shutterstock_332751152.jpg
 

"Global life science and healthcare
investment and consulting company based
in San Francisco, CA and Cambridge, MA"

Hayan Health Networks

About Us

Hayan Health Networks is a life science and healthcare investment and consulting company based in San Francisco and Cambridge, incorporated as the corporate venture arm of Boryung Holding.

Hayan invests in innovation to find new, effective ways to target difficult-to-treat diseases and address current medical unmet needs. By supporting early stage research and development via investments and partnerships, we hope to be a part of innovation in life science and healthcare. 

AUM

FOCUS

$50M

since 2019

Innovative, next generation technologies

Oncology, rare diseases, chronic diseases

Other areas with medical unmet needs

Hayan is the corporate venture arm of Boryung Holdings, and investment and management company headquartered in S. Korea. Boryung Holdings has $500M assets under management and is controlling three healthcare companies: Boryung Pharmaceutical, Boryung Biopharma and Boryung Consumer.

What We do

 

Team

Peter Choi

Chief Executive Officer

Mr. Peter Choi serves as the Chief Executive Officer at Hayan Health Networks, focusing on asset & brand acquisitions, licensing and other global business and scientific collaboration opportunities. He has over 20 years of experience in various aspects of pharmaceutical industries including business development, licensing, commercialization & market access, technology transfer, strategic partnership, and department operations & management.    Read more

  • LinkedIn

Jiwon Huh, Ph.D.

Chief Investment Officer

Dr. Jiwon Huh currently serves as the Chief Investment Officer at Hayan Health Networks, focusing on strategic, early stage investments. With strong scientific and industry expertise in biotech and pharma sectors, Jiwon has been responsible for investments into emerging, innovative biotech companies in North America and other regions and building strategic partnership networks via investments into global venture capital and private equity funds.   Read more

  • LinkedIn
 

Partners

 
 

Portfolio

Global Life Science

PE Fund

Investment: 2019

Global Life Science

VC Fund

Investment: TBA

Korean Life Science

VC Fund

Investment: 2019

Israeli Biotech

Investment: 2020

US Biotech

Investment: 2020

US Biotech

Investment: 2020

ImmPACT Bio

Investment: 2020

Contact Us

845 Market Street, Suite 450

San Francisco, CA 94103

Tel : +1-415-964-4815

  • LinkedIn

© Copyright  Hayan Health Networks. All Right Reserved.